Lavrock Ventures
United States
- McLean, Virginia
- 06/12/2022
- Series B
- $12,000,000
VC fund focused on Post-Seed and Series A investments at the intersection of software, data, cyber, and national security.
- Industry Venture Capital and Private Equity Principals
- Website https://lavrockvc.com/
- LinkedIn https://www.linkedin.com/company/lavrock-ventures/about/
Related People
Daniel HanksInvestor
United States -
Washington, District of Columbia,
Daniel is a Founding General Partner of Lavrock Ventures and has served as an investor, founder, advisor, and operator with a wide variety of early-stage companies.
Prior to founding Lavrock, Daniel gained experience as an investor with JMI Equity, a tech-focused growth equity firm, where he was an active investor in software and technology-enabled services companies and was responsible for sourcing, due diligence, and portfolio company initiatives, and as the VP-Corporate Strategy & Planning with The Teaching Company, a PE-backed consumer media company, where he oversaw FP&A, corporate development, and content partnerships. He also served as a Director with Pagnato Karp, a multi-family office in Reston, VA, and he was also the founder and CEO of SnapDash, a consumer mobile app company in the social photography space. He began his career as an investment banking analyst with McColl Partners.
Daniel has completed early-stage and/or growth equity transactions in various software sectors, including communications, talent management, marketing services, health care, and education.
Iceotope | $26,000,000 | (May 15, 2026)
Novella | $21,000,000 | (May 15, 2026)
Graphon AI | $8,300,000 | (May 15, 2026)
Ranger AI | $8,400,000 | (May 15, 2026)
Chromie Health | $2,000,000 | (May 15, 2026)
Flick | $6,000,000 | (May 15, 2026)
Synthetic | $10,000,000 | (May 14, 2026)
SwishX | $2,200,000 | (May 14, 2026)
Dolfin | $2,460,580 | (May 14, 2026)
Urologic Health | $11,000,000 | (May 14, 2026)